Russell Investments Group Ltd. Acquires 66,315 Shares of Quanterix Co. (NASDAQ:QTRX)

Russell Investments Group Ltd. boosted its position in Quanterix Co. (NASDAQ:QTRX - Free Report) by 19.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 401,476 shares of the company's stock after acquiring an additional 66,315 shares during the quarter. Russell Investments Group Ltd. owned 1.04% of Quanterix worth $4,268,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Bank of New York Mellon Corp boosted its position in shares of Quanterix by 1.8% during the fourth quarter. Bank of New York Mellon Corp now owns 108,186 shares of the company's stock worth $1,150,000 after buying an additional 1,963 shares during the period. Geode Capital Management LLC increased its stake in Quanterix by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 863,503 shares of the company's stock valued at $9,181,000 after buying an additional 4,836 shares during the period. Resona Asset Management Co. Ltd. bought a new stake in shares of Quanterix during the 4th quarter worth about $55,000. American Century Companies Inc. lifted its stake in shares of Quanterix by 9.1% in the 4th quarter. American Century Companies Inc. now owns 71,992 shares of the company's stock worth $765,000 after acquiring an additional 6,023 shares during the period. Finally, KLP Kapitalforvaltning AS bought a new position in shares of Quanterix in the fourth quarter valued at approximately $66,000. 86.48% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on QTRX. Canaccord Genuity Group reduced their price objective on shares of Quanterix from $20.00 to $15.00 and set a "buy" rating for the company in a research report on Tuesday, March 18th. Scotiabank reaffirmed an "outperform" rating on shares of Quanterix in a report on Tuesday, March 25th.

Quanterix Trading Down 5.0 %

QTRX stock traded down $0.26 during trading on Monday, reaching $4.89. 519,032 shares of the stock were exchanged, compared to its average volume of 541,735. The stock has a 50 day simple moving average of $6.74 and a 200-day simple moving average of $9.69. Quanterix Co. has a twelve month low of $4.67 and a twelve month high of $19.18. The company has a market capitalization of $189.68 million, a P/E ratio of -4.61 and a beta of 1.35.

Quanterix (NASDAQ:QTRX - Get Free Report) last released its quarterly earnings results on Monday, March 17th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.27) by ($0.03). Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. The business had revenue of $35.16 million during the quarter, compared to the consensus estimate of $34.93 million. Equities analysts predict that Quanterix Co. will post -0.98 EPS for the current year.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.